Inkef Capital
Edit

Inkef Capital

https://www.inkefcapital.com
Last activity: 24.12.2025
Active
INKEF Capital is an early stage venture capital firm based in Amsterdam. From the very early stages of a technology or lifescience venture, INKEF Capital supports entrepreneurs building their ideas into successful international businesses.

INKEF Capital covers multiple investment stages but focuses mainly on series A investments. For exceptional teams it also considers seed capital to turn a great idea into a company or growth capital to give a running start-up the next push. INKEF Capital is the partner for the long haul.

Focus areas: Technology and Healthcare
Portfolio
1
Mentions
38
Location: Netherlands, North Holland, Amsterdam
Employees: 11-50
Phone:1389902
Founded date: 2010
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A

Portfolio 1

DateNameWebsiteTotal RaisedLocation
18.12.2025TargED Bio...targedbiopharmaceuticals.com$69.42MNetherland...

Mentions in press and media 38

DateTitleDescription
24.12.2025TargED: €21.5 Million Series A Extension Raised To Advance Targeted Thrombolytic TGD001TargED Biopharmaceuticals B.V., a clinical-stage biotech company developing targeted treatments for thrombotic diseases, has closed a €21.5 million Series A extension led by BioGeneration Ventures (BGV). Existing investors, including Andera...
18.12.2025Dutch-based TargED raises €21.5 million Series A extension to advance targeted treatments for thrombotic diseasesDutch clinical-stage BioTech company TargED Biopharmaceuticals has announced the closing of a €21.5 million Series A extension financing to accelerate the clinical development of its targeted thrombolytic, TGD001. The round was led by BioGe...
29.05.2025Salvia BioElectronics: A New Dawn for Migraine SufferersIn the world of chronic pain, migraines reign supreme. They are not just headaches; they are life-altering storms that can sweep away productivity, joy, and social connections. For millions, the search for relief is a relentless journey. En...
27.05.2025Migraines? This Dutch startup just raised €53 million to transform migraine treatment with its ultra-thin implantEindhoven-based Salvia BioElectronics, a clinical-stage medical device company innovating neuromodulation therapy for patients with chronic migraine, today announced the successful completion of their €53 million Series B financing round. T...
17.03.2022Precirix raises EUR 80m in Series B to advance its pipeline of precision radiopharmaceuticalsBrussels, Belgium, 16 March 2022 – Precirix NV, a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology, today announces the closing of a EUR 80m Series B financing round led by new investors INKEF Capit...
15.03.2022Providing “Amazon-level” reach and instant access to over 200 marketplaces, ChannelEngine raises $50 million in Atomico-led roundDutch online marketplace integration platform ChannelEngine has raised $50 million in a Series B funding round. The company's service taps into the growing e-commerce trend of brands selling directly to consumers via marketplaces including ...
20.09.2021Clinical progression and €8M funding for Calypso BiotechCalypso Biotech’s lead program, CALY-002, is a best-in-class therapeutic antibody that binds to and neutralizes interleukin-15 (IL-15). IL-15 controls immune pathways critically involved in disease onset and maintenance, as well as tissue d...
26.08.2021Cardior Raises €64 M Series B to Advance Clinical Pipeline of RNA Therapeutics to Treat Cardiac DiseaseOversubscribed round enables late-stage clinical development of lead candidate, a micro-RNA-132 inhibitor, in heart failure and further accelerates pipeline expansion Hanover, Germany, August 25, 2021 – Cardior Pharmaceuticals, a clinica...
02.06.2021Amsterdam’s financial transaction monitoring system Sentinels trousers £4.9 million in seed roundAmsterdam-based financial transaction monitoring system Sentinels has raised £4.9 million in a seed round led by INKEF Capital. The round also saw participation from a number of Angel Investors including Thijn Lamers and Maikel Lobbezoo, me...
23.04.2021Fresh capital for ONWARD to tackle spinal cord injuries
Show more

Reviews 0

Sign up to leave a review

Sign up Log In